Safety of Ustekinumab in Patients 65 Years or Older With Inflammatory Bowel Disease: A Propensity-Based Match Analysis

被引：0
|
作者：
Kochhar, Gursimran S. [1 ]
Desai, Aakash [2 ]
Dulai, Parambir S. [1 ,3 ]
机构：
[1] Allegheny Hlth Network, Pittsburgh, PA USA
[2] Case Western Reserve Univ, MetroHlth Med Ctt, Cleveland, OH USA
[3] Northwestern Univ, Chicago, IL 60611 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1003
引用
收藏
页码：S727 / S727
页数：1
相关论文
共 50 条
  • [21] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Anjur, Kavya
    Neiman, Nicole
    Kotzen, Alison
    Pond, Stephen
    Goyal, Alka
    GASTROENTEROLOGY, 2022, 162 (07) : S826 - S826
  • [22] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison Borrman
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (05) : S1210 - S1211
  • [23] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (03) : S101 - S102
  • [24] Safety of ustekinumab in inflammatory bowel diseases (IBD): pooled safety analysis through 5 years in Crohn's disease (CD) and 2 years in ulcerative colitis (UC)
    Ghosh, Subrata
    Ott, Elyssa
    Gasink, Christopher
    Miao, Ye
    Colombel, Jean-Frederic
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 107 - 107
  • [25] Efficacy of ustekinumab in biologically naive patients with Inflammatory Bowel Disease
    Subic, Z.
    Novak, G.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1452 - +
  • [26] Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
    Sandborn, William J.
    Feagan, Brian G.
    Danese, Silvio
    O'Brien, Christopher D.
    Ott, Elyssa
    Marano, Colleen
    Baker, Thomas
    Zhou, Yiying
    Volger, Sheri
    Tikhonov, Ilia
    Gasink, Christopher
    Sands, Bruce E.
    Ghosh, Subrata
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (07) : 994 - 1007
  • [27] Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab
    Saleh, Adam
    Stading, Rachel
    Miroballi, Natalia
    Glassner, Kerri
    Abraham, Bincy P.
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (04) : 214 - 221
  • [28] Analysis of the efficacy of intravenous ustekinumab maintenance treatment in patients with refractory Inflammatory Bowel Disease
    Lopez-Saez, B.
    Brunet-Mas, E.
    Melcarne, L.
    Puy, A.
    Lario, S.
    Ramirez-Lazaro, M. J.
    Llovet, L. P.
    Garcia-Sague, B.
    Frisancho, L. E.
    Altadill, A.
    Villoria, A.
    Calvet, X.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1633 - I1633
  • [29] Ustekinumab Monotherapy vs Ustekinumab Combined with Immunomodulators in Inflammatory Bowel Disease: A Propensity-Matched, Retrospective Cohort Study
    Aksan, Feyzullah
    Barrera, Layla
    Ullman, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S774 - S774
  • [30] Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy With Inflammatory Bowel Disease: Stop the Disease, Not the Drug!
    Torres, Joana
    Mahadevan, Uma
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (01) : 28 - 30
12345